Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uninterrupted versus interrupted DOAC therapy for elective colonoscopy with small polypectomy
ACTRN12621001644853Phase 4Not yet recruiting
- Sponsor
- Dr Nicholas Tutticci
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of apixaban, dabigatran and rivaroxaban in thromboembolism, sponsored by Dr Nicholas Tutticci. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
apixabandabigatranrivaroxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on ACTRN12621001644853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001644853.